http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112625090-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112625090-B |
| titleOfInvention | ACE inhibitory peptide for activating cell function and preparation method and application thereof |
| abstract | The invention relates to ACE inhibitory peptide for activating cell function, and a preparation method and application thereof, wherein the ACE inhibitory peptide comprises WAELS and/or WEQFL. According to the invention, the hydrolysate rich in the small molecular peptide is prepared by adopting proper hydrolysis conditions, the ACE inhibitory peptide can further promote the expression of the surface maturation marker molecules CD11c of the TIDCs, the ACE inhibitory peptide CD86 and MHC II, promote the secretion of IL-12 of the TIDCs and inhibit the secretion of IL-10, and shows that the WAELS and WEQFL can further activate the antigen presentation function of the TIDCs with suppressed immune activity, play an important role in specific immune response and have certain efficacy on reducing blood pressure. |
| priorityDate | 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.